Zobrazeno 1 - 10
of 57
pro vyhledávání: '"W A, Katz"'
Family influences on oral PrEP use among adolescent girls and young women in Kenya and South Africa.
Autor:
Makhosazane Nomhle Ndimande-Khoza, Ariana W K Katz, Sinead Moretlwe-Delany, Danielle Travill, Elzette Rousseau, Victor Omollo, Jennifer Morton, Rachel Johnson, Linda-Gail Bekker, Elizabeth A Bukusi, Jared Baeten, Connie Celum, Ariane van der Straten, Sarah T Roberts
Publikováno v:
PLoS ONE, Vol 18, Iss 11, p e0292529 (2023)
IntroductionEffective use of oral HIV pre-exposure prophylaxis (PrEP) has been lower among African adolescent girls and young women (AGYW) than among older women, young men who have sex with men, and serodiscordant heterosexual couples in the region.
Externí odkaz:
https://doaj.org/article/f04e2af61d5745c085fe09a1e78172e6
Autor:
Victor Omollo, Stephanie D. Roche, Felix Mogaka, Josephine Odoyo, Gena Barnabee, Elizabeth A. Bukusi, Ariana W. K. Katz, Jennifer Morton, Rachel Johnson, Jared M. Baeten, Connie Celum, Gabrielle O’Malley
Publikováno v:
Sexual and Reproductive Health Matters, Vol 30, Iss 1 (2022)
Daily oral pre-exposure prophylaxis (PrEP) is being incorporated into services frequented by adolescent girls and young women (AGYW) in sub-Saharan Africa who are at a significant risk of HIV. In non-PrEP studies, positive provider–client rapport h
Externí odkaz:
https://doaj.org/article/15fadc3279aa41d38ec4235dda7239a8
Autor:
Ariana W. K. Katz, Barbara S. Mensch, Kubashni Woeber, Petina Musara, Juliane Etima, Ariane van der Straten
Publikováno v:
BMC Women's Health, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background In biomedical prevention trials, correct and consistent use of the investigational product is crucial to determine efficacy. Product adherence in VOICE, a phase 2B randomized trial of a vaginal gel and oral tablets for HIV prevent
Externí odkaz:
https://doaj.org/article/c12cb271b32b4dc896c8004d031c0fff
Autor:
Elzette Rousseau, Ariana W K Katz, Shannon O'Rourke, Linda-Gail Bekker, Sinead Delany-Moretlwe, Elizabeth Bukusi, Danielle Travill, Victor Omollo, Jennifer F Morton, Gabrielle O'Malley, Jessica E Haberer, Renee Heffron, Rachel Johnson, Connie Celum, Jared M Baeten, Ariane van der Straten
Publikováno v:
PLoS ONE, Vol 16, Iss 10, p e0258542 (2021)
Successful scale-up of PrEP for HIV prevention in African adolescent girls and young women (AGYW) requires integration of PrEP into young women's everyday lives. We conducted interviews and focus group discussions with 137 AGYW PrEP users aged 16-25
Externí odkaz:
https://doaj.org/article/cbadd27d13d9478da1837897139170a9
Autor:
Neetha S. Morar, Leila E. Mansoor, Kalendri Naidoo, Ariana W. K. Katz, Morgan Garcia, Cebo Duma, Nqobile Bonakele Precious Myeni, Themba Tshbalala, Sarita Naidoo, Elizabeth T. Montgomery
Publikováno v:
Journal of acquired immune deficiency syndromes (1999).
The dapivirine vaginal ring ("the ring") reduced HIV acquisition by about 35% in phase III trials, with modeling from open-label extension trials estimating 50% HIV protection with consistent use. The ring may be used without male partner knowledge.
Autor:
Devika Singh, Samantha Siva, Elizabeth T. Montgomery, Carolyne Akello, Lydia Soto-Torres, Morgan Garcia, Ariana W K Katz, Leila E. Mansoor, Florence Mathebula, Mercy Tsidya, Tinei H Chitowa
Publikováno v:
AIDS Behav
Globally, HIV affects women disproportionally to men, particularly in sub-Saharan Africa. While the monthly dapivirine vaginal ring (VR) is a promising female-initiated HIV prevention method, it is important to understand how well the ring is liked.
Autor:
Nomvuyo Mangxilana, Kubashni Woeber, Krishnaveni Reddy, Rachel Scheckter, Thelma Tauya, Chifundo Zimba, Ariane van der Straten, Ariana W K Katz, Juliane Etima, Thesla Palanee-Phillips, Kenneth Ngure, Margaret W. Gichane
Publikováno v:
AIDS Behav
The monthly dapivirine vaginal ring has proven efficacious in reducing HIV incidence in two Phase 3 clinical trials. When considering the potential future availability of the ring to the public, key questions remain about the feasibility of integrati
Autor:
Curtis Dolezal, Susan Nampiira, Clare Kajura-Manyindo, Bryan A. Kutner, Ariane van der Straten, Iván C. Balán, Cody Lentz, Irene Lukas, Rebecca Giguere, Mbongeleni William Buthelezi, Ariana W K Katz, Edith Sitima, Chenai Rushwaya
Publikováno v:
AIDS Care
Biomedical HIV prevention trials increasingly include evidence-based adherence counseling to encourage product use. To retain effectiveness, interventions must contain key components. Monitoring counseling fidelity ensures inclusion of components but
Autor:
Chifundo Zimba, Elmah Manengamambo, Juliane Etima, Krishnaveni Reddy, Florence Mathebula, Morgan Garcia, Mtn, Ariana W K Katz, Zoe Duby, Devika Singh, Mtn Aspire, Elizabeth T. Montgomery, Thesla Palanee-Phillips, Mtn Study teams Hope, Leila E. Mansoor, Lydia Soto-Torres, Sarita Naidoo
Publikováno v:
AIDS Behav
As demonstrated by the Phase III clinical trial, MTN-020/ASPIRE, the monthly dapivirine vaginal ring is well tolerated and reduces the risk of HIV-1 as a woman-initiated prevention option. This analysis uses data from the follow-on MTN-032/ Assessmen
Autor:
Ariane van der Straten, Ariana W K Katz, Kubashni Woeber, Juliane Etima, Petina Musara, Barbara S. Mensch
Publikováno v:
BMC Women's Health, Vol 19, Iss 1, Pp 1-12 (2019)
BMC Women's Health
BMC Women's Health
Background In biomedical prevention trials, correct and consistent use of the investigational product is crucial to determine efficacy. Product adherence in VOICE, a phase 2B randomized trial of a vaginal gel and oral tablets for HIV prevention, was